It has been described that these cerebral structural alterations in preclinical AD follow a biphasic pattern, first developing a thickening of the cortex due to an inflammatory process generated by the sum of the pathogenic effects between Tau and Aβ, followed by a second phase of atrophy where the effect of Tau predominates [48]. This evidence concerns the gene MAPT and Alzheimer disease.